Содержание
- 3. ~ 60 species; Gram-positive or Gram-variable bacilli Large (0.5 x 1.2 to 2.5 x 10 um)
- 4. Diseases Associated with Bacillus
- 5. On blood agar Large, spreading, gray-white colonies, with irregular margins Many are beta-hemolytic (helpful in differentiating
- 7. Bacillus anthracis
- 8. Summary of B. anthracis Infections
- 9. Summary of B. anthracis Infections (cont.)
- 10. Epidemiology of Bacillus anthracis Rare in the US (1974-1990, 17 cases reported by CDC) Enzootic in
- 11. Epidemiology of Bacillus anthracis (cont.) Primarily a disease of herbivorous animals Most commonly transmitted to humans
- 12. Epidemiology of Anthrax in Animal and Human Hosts
- 13. Clinical Presentation of Anthrax Cutaneous Anthrax 95% human cases are cutaneous infections 1 to 5 days
- 14. Clinical Presentation of Anthrax Inhalation Anthrax Virtually 100% fatal (pneumonic) Meningitis may complicate cutaneous and inhalation
- 15. Clinical Presentation of Anthrax Gastrointestinal (Ingestion) Anthrax Virtually 100% fatal Abdominal pain Hemorrhagic ascites Paracentesis fluid
- 16. Treatment & Prophylaxis Treatment Penicillin is drug of choice Erythromycin, chloramphenicol acceptable alternatives Doxycycline now commonly
- 17. Characteristic Bacillus anthracis Other Bacillus spp. Hemolysis Neg Pos Motility Neg Pos (usually) Gelatin hydrolysis Neg
- 19. Bacillus cereus
- 20. Summary of B. cereus Infections
- 21. Summary of B. cereus Infections (cont.)
- 22. Gram-Variable Stain of B. cereus with Endospores
- 23. Foodborne Diseases of B. cereus (Intoxication) (Foodborne Infection)
- 24. Bacillus thurigensis BT corn; Other GMO’s (genetically modified organisms) Bacillus stearothermophilus Spores used to test efficiency
- 26. REVIEW Bacillus
- 27. ~ 60 species; Gram-positive or Gram-variable bacilli Large (0.5 x 1.2 to 2.5 x 10 um)
- 28. Diseases Associated with Bacillus REVIEW
- 29. Review of Bacillus anthracis REVIEW
- 30. Bacillus anthracis REVIEW
- 31. Summary of B. anthracis Infections REVIEW
- 32. Summary of B. anthracis Infections (cont.) REVIEW
- 33. Epidemiology of Anthrax in Animal and Human Hosts REVIEW
- 34. Clinical Presentation of Anthrax Cutaneous Anthrax 95% human cases are cutaneous infections 1 to 5 days
- 35. Clinical Presentation of Anthrax Inhalation Anthrax Virtually 100% fatal (pneumonic) Meningitis may complicate cutaneous and inhalation
- 36. Clinical Presentation of Anthrax Gastrointestinal (Ingestion) Anthrax Virtually 100% fatal Abdominal pain Hemorrhagic ascites Paracentesis fluid
- 37. Treatment & Prophylaxis Treatment Penicillin is drug of choice Erythromycin, chloramphenicol acceptable alternatives Doxycycline now commonly
- 38. Review of Bacillus cereus REVIEW
- 39. Summary of B. cereus Infections REVIEW
- 40. Summary of B. cereus Infections (cont.) REVIEW
- 41. Foodborne Diseases of B. cereus (Intoxication) (Foodborne Infection) REVIEW
- 43. Скачать презентацию